17 September 2024 : Original article
Preoperative Evidence-Based Practice for Prevention of Early Postoperative Infections in Patients Receiving a Liver Transplant
Dong-Xia Wu1AFG, Jing-Xian Hu2AF, Xiu-Lian Wu1AF, Jia-Ning Han1B, Ke-Yi Chang1C, Xiao-Li Quan1DE, Shuang-Mei Xi2AB, Xiao-Lan Wang2DE, Hui-Min Guo2DE, Li-Li Zhang2AEG*DOI: 10.12659/AOT.943610
Ann Transplant 2024; 29:e943610
Table 2 General data of the study subjects.
| Index | Control group (n=24) | Intervention group (n=64) | p-value |
|---|---|---|---|
| Gender (Male/Female) | 23/1 | 52/12 | 0.32* |
| Age | 56 (29, 65) | 54 (29, 67) | 0.61** |
| BMI index | 24.97±4.10 | 24.08±4.02 | 0.34*** |
| Preoperative hospitalization days | 2 (1, 26) | 3 (1, 33) | 0.18** |
| MELD score | 22 (12, 35) | 20 (8, 40) | 0.27** |
| Primary liver cancer | 11 | 25 | – |
| Drug-induced liver injury | 0 | 2 | – |
| Decompensated hepatitis B cirrhosis | 5 | 18 | – |
| Decompensated hepatitis C cirrhosis | 0 | 3 | – |
| Decompensated alcoholic cirrhosis | 1 | 9 | – |
| Liver failure | 5 | 6 | – |
| Autoimmune liver disease | 2 | 1 | – |
| Cholestatic cirrhosis | 0 | 1 | – |
| Spontaneous bacterial peritonitis (SBP) | 0 | 0 | – |
| Receive antibiotics | 5 | 8 | 0.54* |
| Diabetes | 4 | 9 | 0.76* |
| Obesity | 2 | 3 | 0.67* |
| Kidney disease | 3 | 3 | 1.00* |
| * p-value calculated using chi-square test; ** p-value calculated using Mann-Whitney U test; *** p-value calculated using t-test. | |||